Quantonation Ventures, a leading global quantum technology investment fund, has announced a strategic investment from Novo Holdings in its Quantonation II fund. This partnership aims to accelerate the development of quantum technologies addressing critical global challenges, including precision medicine, new materials, and climate change mitigation. Novo Holdings’ investment aligns with its mission to support groundbreaking innovations that create societal and environmental impact, particularly in healthcare and sustainability.
Quantonation, established in 2018, is the world’s largest venture capital fund specializing in quantum technologies. Its first fund, Quantonation I, deployed €91 million across 27 startups, including Pasqal, Qubit Pharmaceuticals, and Multiverse Computing. Quantonation II, targeting €200 million by mid-2025, has already raised €112 million and invested over €30 million in companies like Diraq, Resolve Stroke, and QBlox.
Christophe Jurczak, Managing Partner of Quantonation, emphasized the alignment of Novo Holdings’ vision with Quantonation’s mission to drive the quantum revolution. The collaboration highlights the growing recognition of quantum technologies as transformative tools for solving global challenges.
For more information, refer to the full press release here.
January 28, 2025
Leave A Comment